Sun Pharmaceutical Industries Limited (BOM:524715)
1,885.10
-17.90 (-0.94%)
At close: Nov 20, 2026
BOM:524715 Stock Forecast
Stock Price Forecast
According to 34 analysts polled by S&P Global, BOM:524715 stock has a consensus rating of "Buy" and an average price target of ₹2,112. The average 1-year stock price forecast is 12.03% higher than the current stock price, while the lowest is ₹1,770 (-6.11%) and the highest is ₹2,320 (+23.07%).
Price Target: ₹2,112 (+12.03%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BOM:524715 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 20 | 20 | 19 | 18 | 18 | 19 |
| Buy | 10 | 10 | 10 | 10 | 10 | 10 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 2 | 2 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 34 | 34 | 34 | 33 | 33 | 34 |
Financial Forecast
Revenue This Year
647.80B
from 584.62B
Increased by 10.81%
Revenue Next Year
722.72B
from 647.80B
Increased by 11.57%
EPS This Year
53.55
from 52.01
Increased by 2.96%
EPS Next Year
62.72
from 53.55
Increased by 17.11%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.